Received Jun 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
significant cardiac arrhythmia issues; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ARRHYTHMIA (medically significant), outcome "unknown", described as "significant cardiac arrhythmia issues". Clinical course: The patient developed significant cardiac arrhythmia issues since the administration of Pfizer C19 vaccines. The patient had zero cardiac indications of any kind prior to receiving Pfizer vaccines. The patient has excellent dietary habits and exercise vigorously 6x/week. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.